JP2014503198A5 - - Google Patents

Download PDF

Info

Publication number
JP2014503198A5
JP2014503198A5 JP2013541026A JP2013541026A JP2014503198A5 JP 2014503198 A5 JP2014503198 A5 JP 2014503198A5 JP 2013541026 A JP2013541026 A JP 2013541026A JP 2013541026 A JP2013541026 A JP 2013541026A JP 2014503198 A5 JP2014503198 A5 JP 2014503198A5
Authority
JP
Japan
Prior art keywords
bip
seq
heavy chain
human immunoglobulin
immunoglobulin heavy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2013541026A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014503198A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/061862 external-priority patent/WO2012071422A2/en
Publication of JP2014503198A publication Critical patent/JP2014503198A/ja
Publication of JP2014503198A5 publication Critical patent/JP2014503198A5/ja
Withdrawn legal-status Critical Current

Links

JP2013541026A 2010-11-22 2011-11-22 組換え酵素および他のタンパク質のタンパク質発現および分泌を改善する新規シグナル配列 Withdrawn JP2014503198A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41592610P 2010-11-22 2010-11-22
US61/415,926 2010-11-22
PCT/US2011/061862 WO2012071422A2 (en) 2010-11-22 2011-11-22 Novel signal sequences to improve protein expressions and secretion of recombinant enzymes and other proteins

Publications (2)

Publication Number Publication Date
JP2014503198A JP2014503198A (ja) 2014-02-13
JP2014503198A5 true JP2014503198A5 (cg-RX-API-DMAC7.html) 2015-01-22

Family

ID=46146394

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013541026A Withdrawn JP2014503198A (ja) 2010-11-22 2011-11-22 組換え酵素および他のタンパク質のタンパク質発現および分泌を改善する新規シグナル配列

Country Status (19)

Country Link
US (1) US9279007B2 (cg-RX-API-DMAC7.html)
EP (2) EP3461905B1 (cg-RX-API-DMAC7.html)
JP (1) JP2014503198A (cg-RX-API-DMAC7.html)
KR (2) KR101984318B1 (cg-RX-API-DMAC7.html)
CN (1) CN103328649B (cg-RX-API-DMAC7.html)
BR (1) BR112013012671B1 (cg-RX-API-DMAC7.html)
CA (1) CA2818689C (cg-RX-API-DMAC7.html)
CY (1) CY1121049T1 (cg-RX-API-DMAC7.html)
DK (2) DK3461905T3 (cg-RX-API-DMAC7.html)
ES (2) ES2829199T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20181315T1 (cg-RX-API-DMAC7.html)
HU (1) HUE039070T2 (cg-RX-API-DMAC7.html)
LT (1) LT2643468T (cg-RX-API-DMAC7.html)
PL (1) PL2643468T3 (cg-RX-API-DMAC7.html)
PT (1) PT2643468T (cg-RX-API-DMAC7.html)
RS (1) RS57601B1 (cg-RX-API-DMAC7.html)
SI (1) SI2643468T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201800466T1 (cg-RX-API-DMAC7.html)
WO (1) WO2012071422A2 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3164492B1 (en) * 2014-07-03 2019-10-23 F. Hoffmann-La Roche AG Polypeptide expression systems
EP3443001B1 (en) 2016-04-11 2025-04-30 Obsidian Therapeutics, Inc. REGULATED BIOCIRCUIT SYSTEMS
MY198804A (en) 2017-06-07 2023-09-28 Regeneron Pharma Compositions and methods for internalizing enzymes
CN111936624A (zh) * 2017-11-30 2020-11-13 阿米库斯治疗学公司 Cdkl5表达变体和cdkl5融合蛋白
BR112020016005A2 (pt) 2018-02-07 2020-12-15 Regeneron Pharmaceuticals, Inc. Método de administração de uma proteína terapêutica ao sistema nervoso central, proteína terapêutica multidomínio, polinucleotídeo, vetor de terapia gênica, e, uso de um nucleotídeo que codifica a proteína terapêutica multidomínio
TWI808169B (zh) 2018-04-30 2023-07-11 美商阿米庫斯醫療股份有限公司 基因治療構築體及使用方法
CN112135624B (zh) 2018-05-17 2024-07-19 瑞泽恩制药公司 抗cd63抗体、缀合物和其用途
EP3806888B1 (en) 2018-06-12 2024-01-31 Obsidian Therapeutics, Inc. Pde5 derived regulatory constructs and methods of use in immunotherapy
CA3115944A1 (en) 2018-10-10 2020-04-16 Amicus Therapeutics, Inc. Disulfide bond stabilized polypeptide compositions and methods of use
WO2020086742A1 (en) 2018-10-24 2020-04-30 Obsidian Therapeutics, Inc. Er tunable protein regulation
CN120519489A (zh) * 2018-12-19 2025-08-22 维萨梅布有限公司 编码蛋白质的rna
CA3132840A1 (en) 2019-03-08 2020-09-17 Obsidian Therapeutics, Inc. Human carbonic anhydrase 2 compositions and methods for tunable regulation
AU2020266829A1 (en) * 2019-04-30 2021-11-11 The Trustees Of The University Of Pennsylvania Compositions useful for treatment of Pompe disease
WO2020252404A1 (en) 2019-06-12 2020-12-17 Obsidian Therapeutics, Inc. Ca2 compositions and methods for tunable regulation
CN114450308A (zh) 2019-06-12 2022-05-06 黑曜石疗法公司 用于调节性调控的ca2组合物和方法
US20220348937A1 (en) 2019-09-06 2022-11-03 Obsidian Therapeutics, Inc. Compositions and methods for dhfr tunable protein regulation
CN112342247B (zh) * 2020-11-10 2022-03-11 江苏科技大学 一种提高家蚕细胞表达外源蛋白分泌率的方法
EP4255500A1 (en) 2020-12-01 2023-10-11 The Trustees of The University of Pennsylvania Compositions and uses thereof for treatment of angelman syndrome
WO2023086939A1 (en) 2021-11-12 2023-05-19 Amicus Therapeutics, Inc. Compositions and methods for treating mucopolysaccharidosis iiia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4892132B2 (ja) * 1998-11-24 2012-03-07 ブリストル−マイヤーズ スクイブ カンパニー 70kD熱ショック蛋白による化合物の細胞内標的輸送
EP1689766B1 (en) * 2003-11-06 2012-04-25 Danisco US Inc. Expression in filamentous fungi of protease inhibitors and variants thereof
US20100222554A1 (en) * 2006-04-11 2010-09-02 Thomas Weimer Method of Increasing the In Vivo Recovery of Therapeutic Polypeptides

Similar Documents

Publication Publication Date Title
JP2014503198A5 (cg-RX-API-DMAC7.html)
WO2012071422A3 (en) Novel signal sequences to improve protein expressions and secretion of recombinant enzymes and other proteins
CN105765063B (zh) 应用改变的辅助噬菌体制备抗原结合分子的方法
JP2005120106A5 (cg-RX-API-DMAC7.html)
JP2003524587A5 (cg-RX-API-DMAC7.html)
JP2019521643A5 (cg-RX-API-DMAC7.html)
DK2190863T3 (en) New albumin binding compositions, methods and uses
Zhao et al. Recombinant production of medium-to large-sized peptides in Escherichia coli using a cleavable self-aggregating tag
WO2007130455A3 (en) Compositions and methods for treatment of non-hodgkins lymphoma
JP2018033454A5 (cg-RX-API-DMAC7.html)
CY1112334T1 (el) Ομολογα πολυπεπτιδια il-17 και θεραπευτικες χρησεις αυτων
Gallizia et al. Production of a soluble and functional recombinant streptavidin inescherichia coli
JP2015212284A5 (cg-RX-API-DMAC7.html)
MX2012005864A (es) Proteinas de enlace al antígeno anti-orai 1 y usos de las mismas.
CA2636075A1 (en) Chimaeric fusion protein with superior chaperone and folding activities
JP2016508143A5 (cg-RX-API-DMAC7.html)
JP2021500035A5 (cg-RX-API-DMAC7.html)
RU2016105586A (ru) Гибридная конструкция, включающая антигенсвязывающий фрагмент, специфичный к сывороточному альбумину и эффекторный компонент, и способы ее получения
JP2008509682A5 (cg-RX-API-DMAC7.html)
JP2017526625A5 (cg-RX-API-DMAC7.html)
CN106868025B (zh) 用酵母制备三聚体埃博拉病毒糖蛋白突变体的方法
CN104558181A (zh) 靶向b淋巴瘤细胞的人源单链抗体
JP6199054B2 (ja) 抗イヌIgEモノクローナル抗体並びに抗イヌIgEモノクローナル抗体の重鎖可変領域及び軽鎖可変領域
CN102617734B (zh) 抗FGF-2抗体Dab-2及其应用
CN118496349A (zh) 抗猴痘病毒a35r蛋白的单克隆抗体2d7或其抗体片段